The Global Intraocular Lens Market size is expected to reach $5. 1 billion by 2027, rising at a market growth of 5. 0% CAGR during the forecast period. An intraocular lens is an artificial lens that is implanted in the eye during cataract surgery to replace the natural lens.

New York, April 04, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Intraocular Lens Market Size, Share & Industry Trends Analysis Report By End-use, By Product, By Regional Outlook and Forecast, 2021 - 2027" - https://www.reportlinker.com/p06249505/?utm_source=GNW The worldwide intraocular lens market is predicted to develop as the senior population becomes more sensitive to ocular disorders, cataract prevalence rises, and government measures to eradicate avoidable blindness increase. Furthermore, the market’s growth is aided by an increase in the usage of premium lenses, which provide benefits such as improved visual performance and decreased astigmatism. However, the market is projected to be hampered by an unfavorable reimbursement environment for premium lenses, as well as postoperative problems such as refractive errors. The front face of traditional intraocular lenses is consistently curved from the lens’s centre to its perimeter, resulting in a spherical optical design. However a spherical IOL is simple to make, it does not replicate the form of the natural lens within the eye, which has a varying curvature from centre to periphery. In other words, the normal lens of the eye is aspheric ("not spherical"). Higher-order aberrations (HOAs) are tiny optical flaws caused by a spherical intraocular lens that can impact vision quality, especially in low-light situations like driving at night. The growing number of geriatric and diabetic people, who are more likely to acquire cataracts and other vision problems, is predicted to boost market development. Furthermore, growing awareness of visual impairments, increased healthcare expenditure, and government assistance to develop healthcare infrastructure are among the major drivers driving market expansion. Impact of COVID 19 Routine healthcare visits were cancelled as a result of the COVID-19 outbreak in December 2019, in order to prevent people from catching the virus. In the first half of 2020, this had a negative influence on the market. There was a considerable decline in procedure volumes since many patients were older and at a higher risk of developing COVID-19 symptoms, resulting in revenue loss and the temporary or permanent shutdown of single ophthalmic practise units. Nevertheless, as a consequence of the reopening of several medical institutions and practises in the later part of 2020, patients volumes increased. Furthermore, the use of modified face-to-face visits and telecommunication permitted for the continuation of a modest number of surgeries throughout the pandemic’s height. However, certain operations, such as cataract surgery, are still experiencing a backlog. Market Growth Factors Eye disorders and vision impairment are becoming more common Low vision and blindness are major global public health issues that are becoming more common as a result of demographic shifts and ageing populations. The number and proportion of persons above the age of 65 is increasing. Vision loss is common among the elderly, and it has a negative impact on their quality of life. Losing one’s ability to see is a life-changing event for those who are impacted and their family. But that’s not all: being the most severe ocular problem consequence, blindness indicates a lot about the population’s overall disease burden. As a result, the occurrence of blindness and visual impairment is a good indication of overall health. The demand for refractive surgery evaluation Is growing The segment’s dominance in refractive surgery assessment can be attributed to a rising need to meet the growing number of patients of uncorrected refraction and corneal opacity across the world. Furthermore, cataract surgery is becoming more widely accepted as the best option for recovering eyesight in persons with cataracts. According to World Health Organization (WHO) predictions for 2019, about 123.7 million individuals have visual loss due to uncorrected refractive error, 65.2 million people have cataracts, 6.9 million people have glaucoma, and 4.2 million people have corneal opacity. The Cataract Surgery assessment sector, on the other hand, is estimated to develop the quickest over the forecast period due to growing usage of corneal topographers in the sector due to technological improvements that boost market demand. Market Restraining Factors Trained ophthalmology surgeons are in short availability A World Health Organization examination of 1.5 million individuals that year revealed that around 9 million people were blind, with cataract causing 4 million cases of blindness. In comparison to other medical fields, ophthalmology relies more on specialized equipment and knowledge, and a dearth of both has resulted in a substantial unmet need for eye care centers in the 1.2 billion-strong country. Governments are undertaking measures to improve eye health, but insufficient eye care services and limited funding have hampered plans. End-Use Outlook Based on End-use, the market is segmented into Hospitals, Ophthalmic Clinics, Eye Research Institutes, and Ambulatory Surgery Centers. Because the majority of cataract and vision correction procedures are conducted in hospitals, the hospitals sector led the market in 2021. Individual ophthalmic clinics are increasing in number in developing countries. There are no hospitals associated with these clinics. The rivalry among service providers is projected to heat up as the number of eye care practitioners and clinics grows. The provision of treatments at low pricing is likely to boost the number of people choosing these clinics for treatment, fuelling segment expansion. Product Outlook Based on Product, the market is segmented into Multifocal, Monofocal, Toric, and Accommodative. The toric intraocular lens sector, which is advantageous primarily for patients with moderate to high astigmatism, was the second-largest segment in 2021 and is predicted to rise at a profitable pace throughout the projection period. Astigmatism causes myopia, hypermetropia, or both in patients. Toric intraocular lenses are made particularly for such people. Furthermore, toric IOLs are meant to minimize the necessity for incision implants, which were previously necessary during astigmatism surgical operations, enhancing their popularity among people. Regional Outlook Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. Asia Pacific is predicted to expand at the quickest rate. The existence of a high elderly and diabetic population, both of whom are susceptible to cataracts and other ocular illnesses, is driving the market in this area. Furthermore, the market is growing due to increased knowledge of improved treatment alternatives and an inflow of people from wealthy nations seeking cheap healthcare. The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include EyeKon Medical, Inc., Lenstec, Inc., HumanOptics AG, STAAR Surgical Company, Rayner Intraocular Lenses Limited, Bausch Health Companies, Inc., Carl Zeiss AG, Johnson & Johnson (Johnson & Johnson Vision Care, Inc.), Hoya Corporation, and Alcon, Inc. Strategies Deployed in Intraocular Lens Market Nov-2020: Alcon launched AcrySof IQ Vivity, a first-of-its-kind, surgical lens. This lens is designed for cataract patients to treat presbyopia, a common, age-related vision condition caused by the gradual loss of the eye’s ability to focus on close objects. In addition, this latest innovation in Alcon’s portfolio of presbyopia-correcting intraocular lenses, AcrySof IQ Vivity utilizes a non-diffractive design called X-WAVE technology that sets apart it from other intraocular lenses currently on the market. Oct-2020: Bausch + Lomb launched SimplifEYE intraocular lens (IOL) delivery system in the US. SimplifEYE IOL provides a delivery system for the enVista MX60PL and the enVista toric MX60PT monofocal preloaded intraocular lenses (IOLs). It offers easy and consistent implantation of enVista lenses into the capsular bag in three steps through an incision as small as 2.2mm. Sep-2020: Rayner introduced RayOne EMV, a new fully loaded non-diffractive IOL. This product is designed to enhance patient results achieved with monovision. RayOne EMV expands a patient’s range of vision with a patented non-diffractive aspheric optic profile. May-2020: Bausch + Lomb released its first presbyopia-correcting intraocular lens (IOL), LuxSmart, and its monofocal version, LuxGood. In addition, both of these lenses feature preloaded delivery systems and Pure Refractive Optics (PRO) Technology. Dec-2019: Johnson & Johnson received the FDA approval for the Tecnis Toric II one-piece intraocular lens (IOL). This product provides more surface texture and friction on IOL haptics, which holds an IOL in position within the eye. In addition, this lens would deliver visual improvement for different visual conditions and lifestyles. Dec-2019: Bausch + Lomb introduced enVista toric MX60ET hydrophobic acrylic intraocular lens (IOL). The MX60ET with StableFlex technology includes advanced material properties that offer enhanced optic recovery following delivery during cataract surgery. Mar-2019: Alcon took over PowerVision, a US-based medical device development company. This acquisition aimed to bring the innovative, accommodating lens to cataract patients across the globe. Scope of the Study Market Segments covered in the Report: By End-Use • Hospitals • Ophthalmic Clinics • Eye Research Institutes • Ambulatory Surgery Centers By Product • Multifocal • Monofocal • Toric • Accommodative By Geography • North America o US o Canada o Mexico o Rest of North America • Europe o Germany o UK o France o Russia o Spain o Italy o Rest of Europe • Asia Pacific o China o Japan o India o South Korea o Singapore o Malaysia o Rest of Asia Pacific • LAMEA o Brazil o Argentina o UAE o Saudi Arabia o South Africa o Nigeria o Rest of LAMEA Companies Profiled • EyeKon Medical, Inc. • Lenstec, Inc. • HumanOptics AG • STAAR Surgical Company • Rayner Intraocular Lenses Limited • Bausch Health Companies, Inc. • Carl Zeiss AG • Johnson & Johnson (Johnson & Johnson Vision Care, Inc.) • Hoya Corporation • Alcon, Inc. Unique Offerings • Exhaustive coverage • Highest number of market tables and figures • Subscription based model available • Guaranteed best price • Assured post sales research support with 10% customization free Read the full report: https://www.reportlinker.com/p06249505/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________

(Bloomberg) -- Russia’s state oil producing giant Rosneft PJSC surprised traders in Europe and Asia with offers to sell large amounts of crude at speed, as well as setting out significant changes to the payment process for at least some of the cargoes.Most Read from BloombergKremlin Insiders Alarmed Over Growing Toll of Putin’s War in UkraineNetflix Craters After Shock Subscriber Drop, ‘About-Face’ on AdsUkrainian Troops Risk Being Encircled in New Russian OffensiveIn Defense of Elon Musk's Mana

Biotech stocks are down big since last summer. The media's focus on gene editing, messenger RNA (mRNA), and monoclonal antibodies may have waned, but some patients are already benefiting. Admittedly, shares of Regeneron are doing just fine.

Cassava Sciences, Inc.'s (NASDAQ:SAVA) a clinical stage biotechnology company, is developing a drug for Alzheimer - a neurodegenerative disease, affecting more than 35.7 million people worldwide (6 million in the US). In this article, we will review Cassava's product line and cash capacity to fund further research until FDA approval.

Netfix (NFLX) shares are tanking 35% on Wednesday afternoon, their worst daily performance since 2004 after an unexpected decline in first-quarter net subscribers.

Much as Intuitive Surgical redefined the surgical field, this company is updating how abnormal heart rhythms are diagnosed.

Tesla reported a stunning profit, even after excluding regulatory tax credits, as demand continues unabated after a price hike.

Boeing Co has advised key airlines and parts suppliers that 787 Dreamliner deliveries would resume in the second half of 2022, a crucial landmark for an industry eager for a post-COVID recovery, three people familiar with the matter said. Boeing's swollen 787 inventory, amassed since it halted deliveries nearly a year ago over structural flaws, has locked up desperately needed cash and cut airline capacity. Resuming deliveries is also key to Boeing's plans for step-by-step 787 production increases in the coming months - vital to propping up a supply chain that has weathered successive crises.

As Netflix searches for new subscribers amid a big downturn, the streaming giant is looking to end password sharing.

(Bloomberg) -- China more than doubled imports of steel-making coal from Russia in March, procuring the fuel at a discount as other nations move to ban deliveries due to the war in Ukraine. Most Read from BloombergKremlin Insiders Alarmed Over Growing Toll of Putin’s War in UkraineNetflix Breaks Its Own Rules After Subscriber Losses Batter SharesIn Defense of Elon Musk's Managerial ExcellenceUkrainian Troops Risk Being Encircled in New Russian OffensiveUkraine Update: Mariupol on Brink; China St

(Bloomberg) -- Qatar is sounding out buyers about a further expansion of its liquefied natural gas capacity, according to people familiar with the matter, as Europe rushes to secure supplies in the wake of Russia’s war in Ukraine.Most Read from BloombergKremlin Insiders Alarmed Over Growing Toll of Putin’s War in UkraineNetflix Rout Is Worst Since 2004, Punishing Roku and Disney, TooUkrainian Troops Risk Being Encircled in New Russian OffensiveUkraine Update: Mariupol on Brink; China Stands With

The energy sector is composed of companies focused on the exploration, production, and marketing of oil, gas, and renewable resources around the world. Energy sector stocks include upstream companies that primarily engage in the exploration of oil or gas reserves, such as Devon Energy Corp. Downstream companies include Marathon Petroleum Corp., which refines and processes oil and gas products for delivery to consumers. Among the industry's biggest players are Chevron Corp. and ExxonMobil Corp.

(Bloomberg) -- An already sweltering summer and acute coal shortages are triggering blackouts across parts of India, raising fears of a new power crisis that could roil Asia’s third-biggest economy.Most Read from BloombergKremlin Insiders Alarmed Over Growing Toll of Putin’s War in UkraineNetflix Rout Is Worst Since 2004, Punishing Roku and Disney, TooAckman Loses More Than $430 Million on 3-Month Netflix BetUkrainian Troops Risk Being Encircled in New Russian OffensiveRussia Test-Fires Nuclear-

The company's immunology drug Rinvoq was given the go-ahead to treat adult patients with moderate-to-severe ulcerative colitis.

(Bloomberg) -- Tesla Inc. chief executive officer Elon Musk told a judge he shouldn’t be prohibited from talking about his fight with the U.S. Securities and Exchange Commission, as shareholders suing him have requested.Most Read from BloombergKremlin Insiders Alarmed Over Growing Toll of Putin’s War in UkraineNetflix Rout Is Worst Since 2004, Punishing Roku and Disney, TooUkrainian Troops Risk Being Encircled in New Russian OffensiveUkraine Update: Mariupol on Brink; China Stands With MoscowBil

The European Union has taken its first step at sanctioning Russian energy by placing an import ban on Russian coal. But further sanctions on oil and natural gas would hit the continent much harder—and it has few other options.

KeyBanc sets a Wall Street-low price target for shares of Alphabet. The analyst still thinks it's a good bet heading into earnings season.

Who joins GOOGL stock and Microsoft on this screen of Warren Buffett stocks based on the investing strategy of the Berkshire Hathaway CEO?

(Bloomberg) -- JPMorgan Chase & Co. was removed as the most senior underwriter for Kingsoft Cloud Holdings Ltd.’s Hong Kong stock offering after one of the bank’s analysts cut the share-price target for the Chinese technology company by half, people familiar with the matter said.Most Read from BloombergNetflix Breaks Its Own Rules After Subscriber Losses Batter SharesKremlin Insiders Alarmed Over Growing Toll of Putin’s War in UkraineIn Defense of Elon Musk's Managerial ExcellenceUkrainian Troop

No matter how much or how little money you have, you should structure your withdrawals thoughtfully.

Photo Illustration by The Daily Beast/GettyThanks to the success of an initial safety trial for an implantable device that can translate the brain’s electrical impulses into readable signals, we’re a step closer to being able to text—or otherwise interface with our devices—using just our thoughts.Best of all, this new brain-computer interface (BCI)—“brain modem,” if you will—doesn’t require a hole in your head. It does, however, require a hole in your chest. And that’s just one factor that could